Kapstone Financial Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.83M Buy
7,477
+230
+3% +$53.6K 0.9% 25
2025
Q4
$1.5M Hold
7,247
0.75% 26
2025
Q3
$1.34M Sell
7,247
-557
-7% -$95.4K 0.63% 26
2025
Q2
$1.19M Buy
7,804
+336
+4% +$51.6K 0.59% 28
2025
Q1
$1.24M Sell
7,468
-100
-1% -$15.6K 0.7% 27
2024
Q4
$1.14M Sell
7,568
-261
-3% -$40.4K 0.61% 28
2024
Q3
$1.26M Sell
7,829
-16
-0.2% -$2.55K 0.77% 26
2024
Q2
$1.15M Sell
7,845
-66
-0.8% -$9.82K 0.75% 29
2024
Q1
$1.25M Sell
7,911
-40
-0.5% -$6.37K 0.85% 27
2023
Q4
$1.27M Sell
7,951
-295
-4% -$45.2K 0.99% 20
2023
Q3
$1.28M Sell
8,246
-290
-3% -$47.9K 1.16% 19
2023
Q2
$1.44M Sell
8,536
-142
-2% -$22.9K 1.19% 16
2023
Q1
$1.44M Sell
8,678
-55
-0.6% -$8.88K 1.3% 15
2022
Q4
$1.45M Buy
+8,733
New +$1.51M 1.32% 15

Other funds holding JNJ

Kapstone Financial Advisors's JNJ Position: Q1 2026 in Review

Kapstone Financial Advisors increased its Johnson & Johnson (JNJ) stake by 3.2% in Q1 2026, buying an estimated $53.6K and bringing the position to 7,477 shares worth $1.83M. The position accounts for 0.9% of the portfolio, ranked #25.

Kapstone Financial Advisors first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Kapstone Financial Advisors held 7,477 shares of Johnson & Johnson worth $1.83M as of Q1 2026.
  • Kapstone Financial Advisors bought 230 Johnson & Johnson shares in Q1 2026, an estimated $53.6K.
  • Johnson & Johnson made up 0.9% of Kapstone Financial Advisors's portfolio in Q1 2026, its #25 holding.
  • Kapstone Financial Advisors first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Kapstone Financial Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.